Headaches and psoriatic arthritis | Acibadem Health Point
Additionally, some medications used to treat psoriatic arthritis might contribute to headache symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologic …
Treatment Options for Psoriatic Arthritis
Treatment Options for Psoriatic Arthritis A combination of medication, exercise, and complementary therapies can improve skin symptoms and joint pain. By Stephanie Watson | …
Biologics for Psoriasis and Psoriatic Arthritis
Biologics work for psoriasis and psoriatic arthritis by blocking the actions of the certain immune cells or responses that play a role in the development of psoriasis or psoriatic arthritis. In some …
Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
Biologic therapies for treatment of psoriasis and psoriatic arthritis. The biologic drugs discussed are categorized below and placed alongside their FDA approval year.
Taking A Look At Biologic Medications For Psoriatic Arthritis
Biologics are used to treat people with moderate to severe psoriatic arthritis. This treatment option is usually a final resource to treat pain.
Innovative Treatments for Psoriatic Arthritis: What’s New in 2024?
Jul 11, 2024 · Here’s a look at what’s new in the treatment landscape for psoriatic arthritis in 2024. Advances in Biologic Therapies for Psoriatic Arthritis Biologic therapies and drugs for …
FAQs | BIMZELX® (bimekizumab‐bkzx) for Psoriatic Arthritis
Most biologic psoriatic arthritis treatments target or block just one of the proteins in your body believed to drive the inflammation that causes pain, swelling, and stiffness. BIMZELX works …
Comparative effectiveness of cycling versus swapping to UL-17 ...
Nov 24, 2025 · The increase in biological disease-modifying antirheumatic drugs for psoriatic arthritis (PsA) made it possible to consider different mechanisms of action (MoA) after the …
Consensus definitions of complex-to-manage and treatment
5 days ago · Despite advances in the treatment of psoriatic arthritis (PsA), a substantial proportion of patients continue to report persistent symptoms and impaired quality of life.
Intensive biological DMARD-first strategy versus standard step-up …
Nov 20, 2025 · Background Treat-to-target strategies have previously been shown to improve outcomes in psoriatic arthritis. We aimed to evaluate whether a treat-to-target strategy using …